-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics director Lori Anne Kunkel sells common shares worth $344,513.56

PUBT·06/09/2026 20:49:48
Listen to the news
Enliven Therapeutics director Lori Anne Kunkel sells common shares worth $344,513.56
  • Enliven Therapeutics director Lori Anne Kunkel sold 10,000 common shares on June 5, 2026.
  • Sales priced at USD 34.28, USD 35.36, USD 35.82 per share, based on weighted-average prices.
  • She held 51,884 common shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001536368-26-000004), on June 09, 2026, and is solely responsible for the information contained therein.